Challenges to Treatment of Chronic Pain and Addiction During the “Opioid Crisis”

Current Pain and Headache Reports

Volumn 20, Issue 12, 2016, Pages

  Krashin, Daniel ^a   Murinova, Natalia ^a   Sullivan, Mark ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Chronic pain; Heroin; Opioid crisis; Opioid overdose; Opioid use disorder; Public health

Indexed keywords

OPIATE;

ANALGESIA; AWARENESS; CHRONIC PAIN; CLINICAL DECISION MAKING; DRUG CONTROL; DRUG EFFICACY; DRUG MISUSE; DRUG SAFETY; HEALTH CARE ACCESS; HUMAN; MAINTENANCE THERAPY; OPIATE ADDICTION; PAIN SEVERITY; PATIENT SATISFACTION; PRESCRIPTION; REVIEW; TREATMENT RESPONSE; PUBLIC HEALTH; UNITED STATES;

CHRONIC PAIN; HUMANS; OPIOID-RELATED DISORDERS; PUBLIC HEALTH; UNITED STATES;

EID: 84996956353     PISSN: 15313433     EISSN: 15343081     Source Type: Journal    
DOI: 10.1007/s11916-016-0596-2     Document Type: Review

References (17)

1. Daubresse M, Chang H-Y, Yu Y, et al. Ambulatory diagnosis and treatment of non-malignant pain in the United States, 2000–2010. Medical care. 2013;51(10).
2. Kolodny A, Courtwright DT, Hwang CS, et al. The prescription opioid and heroin crisis: a public health approach to an epidemic of addiction. Ann Rev Public Health. 2015;36:559–74.
3. Center for Disease Control. CDC’s top ten: 5 health achievements in 2013 and 5 health threats in 2014. Atlanta, GA: CDC. http://blogs.cdc.gov/cdcworksforyou24-7/2013/12/cdc%E2. 2014;80.
4. Franklin G, Sabel J, Jones CM, et al. A comprehensive approach to address the prescription opioid epidemic in Washington State: milestones and lessons learned. Am J Public Health. 2015;105(3):463–9.
5. Martin BC, Fan MY, Edlund MJ, Devries A, Braden JB, Sullivan MD. Long-term chronic opioid therapy discontinuation rates from the TROUP study. J Gen Intern Med. 2011;26(12):1450–7.
6. Goesling J, Henry MJ, Moser SE, et al. Symptoms of depression are associated with opioid use regardless of pain severity and physical functioning among treatment-seeking patients with chronic pain. J Pain. 2015;16(9):844–51.
7. Upadhyay J, Maleki N, Potter J, et al. Alterations in brain structure and functional connectivity in prescription opioid-dependent patients. Brain: J Neurol. 2010;133(7):2098–114.
8. Younger JW, Chu LF, D’Arcy NT, Trott KE, Jastrzab LE, Mackey SC. Prescription opioid analgesics rapidly change the human brain. Pain. 2011;152(8):1803–10.
9. Scherrer JF, David Schneider F, Lustman PJ. Opioid analgesics and chronic non-cancer pain: a prescription for research in primary care. Fam Pract. 2016.
10. Scherrer JF, Salas J, Copeland LA, et al. Response to Ruan et al. Letter to the editor: increased risk of depression recurrence after initiation of prescription opioids in noncancer pain patients. J Pain. 2016;17(8):946–7.
11. Scherrer JF, Salas J, Copeland LA, et al. Increased risk of depression recurrence after initiation of prescription opioids in noncancer pain patients. J Pain. 2016;17(4):473–82.
12. Scherrer JF, Salas J, Sullivan MD, et al. The influence of prescription opioid use duration and dose on development of treatment resistant depression. Prev Med. 2016;91:110–6.
13. Franklin GM, Fulton-Kehoe D, Turner JA, Sullivan MD, Wickizer TM. Changes in opioid prescribing for chronic pain in Washington State. J Am Board Fam Med. 2013;26(4):394–400.
14. Robinson PJ, Reiter JT. Prescription drug abuse in primary care. Behavioral Consultation and Primary Care: Springer; 2016:269–286.
15. Wiedemer NL, Harden PS, Arndt IO, Gallagher RM. The opioid renewal clinic: a primary care, managed approach to opioid therapy in chronic pain patients at risk for substance abuse. Pain Med. 2007;8(7):573–84.
16. Cicero TJ, Ellis MS, Harney J. Shifting patterns of prescription opioid and heroin abuse in the United States. N Engl J Med. 2015;373(18):1789–90.
17. Peavy KM, Banta-Green CJ, Kingston S, Hanrahan M, Merrill JO, Coffin PO. “Hooked on” prescription-type opiates prior to using heroin: results from a survey of syringe exchange clients. J Psychoactive Drugs. 2012;44(3):259–65.